Umer Raffat's Stock Ratings

Evercore ISI Group Analyst

Umer Raffat is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/16/2024

Overall Average Return

-8.93%

Smart Score

43.2%

Overall Average Return Percentile

21st

Number of Ratings

14
Buy NowGet Alert
07/16/2024SYREBuy Now
Spyre Therapeutics
$29.74Initiates → OutperformGet Alert
03/08/2024AMLXBuy Now
Amylyx Pharma
$2.38DowngradeOutperform → In-LineGet Alert
02/28/2024GUTSBuy Now
Fractyl Health
$4.54Initiates → OutperformGet Alert
02/16/2024RAPTBuy Now
RAPT Therapeutics
$3.73Initiates → OutperformGet Alert
10/24/2023ALKSBuy Now
Alkermes
$23.70UpgradeIn-Line → OutperformGet Alert
06/21/2023CNTABuy Now
Centessa Pharmaceuticals
$9.54Initiates → OutperformGet Alert
05/18/2023TEVABuy Now
Teva Pharmaceutical Indus
$16.72UpgradeIn-Line → OutperformGet Alert
05/11/2023PHATBuy Now
Phathom Pharmaceuticals
$12.29UpgradeIn-Line → OutperformGet Alert
03/07/2023MLYSBuy Now
Mineralys Therapeutics
$14.58Initiates → OutperformGet Alert
11/02/2022LEGNBuy Now
Legend Biotech
$56.18Initiates → OutperformGet Alert
09/13/2022CEREBuy Now
Cerevel Therapeutics Hldg
$42.44Initiates → OutperformGet Alert
05/06/2022PHATBuy Now
Phathom Pharmaceuticals
$12.29DowngradeOutperform → In-LineGet Alert
02/02/2022AMLXBuy Now
Amylyx Pharma
$2.38Initiates → OutperformGet Alert
03/19/2018PIRSBuy Now
Pieris Pharmaceuticals
$7.5073.33% → $1040Initiates → OutperformGet Alert